Why life reaches for metals at all
By now the moves should feel familiar: a metal ion sits at the centre of a coordination sphere, ligands donate lone pairs into its empty orbitals, and the geometry, oxidation state, and electron count decide what it can do. A metalloenzyme is nothing more exotic than this — a protein that wraps itself around one or a few metal ions and uses them to do chemistry that pure organic side-chains simply cannot. The protein is the bespoke ligand set, folded into exactly the right shape; the metal is the reactive heart. Roughly a third to a half of all known enzymes need a metal to work, which is why the essential metals of life — iron, zinc, copper, manganese, magnesium, cobalt, molybdenum, and more — read like a stroll across the d-block and beyond.
Metals earn their place because they offer three things carbon cannot. First, a positive ion is a Lewis acid that grips and polarises substrates — it can hold a water molecule and tug so hard on its O–H bond that the proton falls off far more easily than it ever would in free water. Second, the redox-active metals shuttle between oxidation states (Fe2+ / Fe3+, Cu+/Cu2+, Mn through several) and so can hand electrons in and out one at a time, exactly the trick that pure organic chemistry struggles with. Third, a metal can hold several ligands at once around a defined geometry, lining up two or three reacting partners next to each other. The whole earlier rung on enzyme catalysis as coordination chemistry now pays off: an active site is a coordination complex with a job.
Zinc as a Lewis-acid scalpel: carbonic anhydrase
Not every essential metal is there to juggle electrons. Zinc is the great exception and the great teacher: as Zn2+ it has a filled d10 configuration, so it has no redox chemistry to speak of and no crystal-field colour — it is colourless and stays firmly +2. What it offers instead is a small, hard, doubly charged ion that is a superb Lewis acid yet, unlike Fe or Cu, will not generate damaging radicals. That is exactly what you want for a chemical scalpel that has to work millions of times without rusting. Carbonic anhydrase is the textbook case, one of the fastest enzymes known, and it does a deceptively dull-sounding job: turning carbon dioxide and water into bicarbonate, CO2 + H2O -> HCO3- + H+, the reaction that lets your blood carry CO2 away from tissues and dump it at your lungs.
The structure is a small picture worth holding. A single Zn2+ sits at the bottom of a cone-shaped pocket, held by three nitrogen donor atoms from three histidine side-chains, leaving one coordination site of its near-tetrahedral geometry pointing up into the cavity. On that fourth site sits a water molecule. Here is the chemistry: Zn2+ is such a strong Lewis acid that bonding to it drains electron density off the bound water, weakening its O–H bond so much that the water gives up a proton at body pH — something free water almost never does. The enzyme has manufactured a hydroxide ion, Zn–OH, hanging right where it is needed, far more reactive than any hydroxide floating in solution.
- Activate: Zn2+ binds a water and, as a strong Lewis acid, strips its proton to leave a poised Zn–OH nucleophile at the active site.
- Attack: a CO2 molecule drifts into the pocket and the Zn–OH oxygen attacks its carbon, building the C–O bond of bicarbonate.
- Release: the newly made bicarbonate, HCO3-, leaves and a fresh water takes its place on the zinc, ready to be deprotonated again.
- Reset: a final proton transfer through a relay of water and protein groups regenerates the Zn–OH, and the cycle repeats up to a million times a second.
Read that cycle against the catalytic loop from the principles guide and it is the same skeleton — activate, react, release, reset — with the metal lowering the barrier and emerging unchanged each turn. The lesson generalises: a great many zinc enzymes (in your digestion, your DNA-reading machinery, your immune system) use Zn2+ in just this way, as a redox-silent Lewis acid that polarises a substrate or generates a hydroxide on demand. Where life needs a clean cut and not a spark, it reaches for zinc.
The hardest jobs: splitting N2 and splitting water
Two reactions in all of chemistry stand out as brutally hard, and life solves both with clusters of metals rather than a lone ion. The first is breaking the famously inert triple bond of dinitrogen, N2. Industry does this in the Haber–Bosch process at hundreds of degrees and hundreds of atmospheres; you met that iron catalyst back in ammonia synthesis. Yet bacteria in soil and root nodules carry out the same nitrogen fixation at ordinary temperature and pressure, using the enzyme nitrogenase. Its heart is the iron–molybdenum cofactor, the FeMo-co, a cage of seven iron atoms and one molybdenum laced together by sulfur bridges with a single light carbon atom buried at the very centre — a structure so strange it was only fully solved in 2011.
Why a cluster and not one metal? Because reducing N2 all the way to two molecules of ammonia requires shovelling in eight electrons and eight protons in a tightly choreographed sequence, and N2 binds so reluctantly that the metals must store and deliver those electrons in a controlled trickle. A multi-metal cluster is an electron reservoir — its many accessible metal oxidation states let it bank reducing equivalents one at a time and release them onto a clinging N2 molecule, weakening that triple bond bit by bit until it finally cracks. Be honest about the limits of our knowledge here: the exact place N2 binds and the precise order of the steps are still debated, and nitrogenase wastefully makes one H2 for every N2 it fixes. We do not yet have a synthetic catalyst that matches it at room temperature, which is why Haber–Bosch still burns roughly one to two percent of the world's energy.
The second brutal job is the one your existence ultimately rests on: tearing electrons and protons out of water itself. Every oxygen molecule you have ever breathed was made by the oxygen-evolving complex at the heart of photosystem II, the engine of photosynthesis. Its active site is a tiny cluster of four manganese atoms and one calcium, bridged by oxygen atoms into a lopsided cube — often written Mn4CaO5. Sunlight, captured by chlorophyll nearby, drives this cluster up a ladder of five oxidation states (the famous S0 through S4 states). At each rung it parks one more oxidising equivalent, and only when it has stored four does it have enough oxidising power to do the near-impossible in one concerted snap: 2 H2O -> O2 + 4 H+ + 4 e-, releasing the oxygen and resetting to the bottom of the ladder.
Cisplatin: when a complex's slowness is the drug
Now turn from enzymes to medicine, where the most celebrated inorganic drug is a small square-planar platinum complex discovered almost by accident. Cisplatin is cis-[PtCl2(NH3)2]: a Pt2+ centre, which (like other d8 ions) prefers a square-planar geometry, carrying two ammonia ligands and two chloride ligands arranged cis — next to each other, not across. The geometry is the whole story. The trans isomer, with the chlorides opposite each other, is essentially inactive as a drug. Same atoms, same formula, different arrangement, utterly different medicine — a vivid reminder of why the isomerism you learned in coordination chemistry is not bookkeeping but biology.
How does it work? Cisplatin is injected into the blood, where the chloride concentration is high enough to keep the two Pt–Cl bonds intact — the complex is kinetically slow to react, and that slowness lets it travel. Once it slips inside a cell, the chloride concentration plummets, and now the two chlorides are slowly swapped for water (aquated). Those aqua ligands are far better leaving groups, and the activated platinum drifts to DNA and binds, displacing them to form Pt–N bonds to the nitrogen of guanine bases. Because the two reactive sites are cis, it can clamp onto two neighbouring guanines on the same strand at once, kinking the DNA double helix. That kink jams the machinery that copies and reads DNA; a cell that cannot copy its DNA cannot divide, and a cancer cell that cannot divide dies.
Two threads from earlier rungs are quietly doing all the work. First, kinetic inertness, not thermodynamic stability: the Pt–Cl bonds are not unbreakable, just slow to break, and platinum(II) complexes are famously sluggish to substitute — that deliberate slowness is what lets a reactive metal survive the bloodstream long enough to reach its target. Second, the trans effect you met in substitution mechanisms governs exactly which ligand leaves and in what order, and chemists exploit it to build the drug as the cis isomer in the first place. Cisplatin is harsh — its side-effects come from binding DNA in healthy cells too — which is why later platinum drugs like carboplatin swap the chlorides for ligands that aquate even more slowly, trading some potency for gentler, more controlled reactivity.
Chelation and contrast: pulling poison out, lighting pictures up
If cisplatin uses a metal to harm a cell on purpose, the other half of inorganic medicine uses ligands to undo the harm metals do. When someone is poisoned by lead, mercury, arsenic, or iron overload, the cure is chelation therapy: dosing the patient with a chelating ligand — a molecule with several donor atoms that wrap around a single metal ion like a claw — that grips the toxic metal far more tightly than the body's own proteins can, forming a stable, water-soluble complex that the kidneys flush away. Drugs like EDTA, dimercaprol, and deferoxamine are exactly such multi-toothed ligands, each tuned to the metal it must catch.
Why does a chelating ligand win the tug-of-war? This is the chelate effect from the stability-constants rung, working as medicine. Wrapping one molecule with many arms around a metal releases several small ligands (often water) it was holding, raising the entropy of the solution — many free particles where there were few — so the multidentate complex is dramatically more stable than the same donor atoms arriving on separate molecules. And selectivity follows the HSAB principle you learned: soft donor atoms like sulfur are chosen for soft toxic ions like mercury and lead, while hard oxygen donors are chosen for hard ions like iron(III). A chelation drug is HSAB and the chelate effect, prescribed.
The same chelating trick, turned to imaging, gives the gadolinium MRI contrast agents that brighten a scan. An MRI watches the hydrogen nuclei of water, and Gd3+ — a lanthanide with seven unpaired f electrons — is fiercely paramagnetic, so it speeds up how fast nearby water protons relax and thereby makes those tissues glow brighter in the image. The catch: free Gd3+ is toxic, close in size to Ca2+ and able to jam calcium machinery. The fix is again chelation — Gd3+ is locked inside a tight multidentate (often macrocyclic) cage so stable that the ion stays caged through the scan and is excreted intact, while still leaving one site open for water to come and go. Honesty matters here too: these agents are extremely safe but not perfect, and concern over slow gadolinium retention has pushed medicine toward the most kinetically inert, cage-like complexes — kinetic inertness saving the day once more, just as it did for cisplatin.
ENZYMES (metal as worker) MEDICINE (metal or ligand as tool)
Zn2+ carbonic anhydrase cisplatin cis-[PtCl2(NH3)2]
d10, Lewis acid, no redox d8 square planar -> binds DNA
FeMo nitrogenase chelation EDTA / dimercaprol
cluster, N2 + 8e- -> 2 NH3 multidentate claw pulls out poison
Mn4Ca oxygen-evolving complex Gd-MRI Gd3+ caged in macrocycle
5 redox states, 2 H2O -> O2 7 unpaired f e-, paramagnetic